We are innovating and digitalising RNA vaccine and therapeutics manufacturing platform processes. Our continuous production processes will allow rapid, high-volume production of high-quality, low-cost vaccines and therapeutics in a disease-agnostic manner.
Lecturer (Assistant Professor) at The University of Sheffield
Doctor of Philosophy (PhD), Bioengineering